Marshall Urist, EVP, Research & Investments: Royalty Pharma RPRX Sell · Filed 25/12/22

Trade details

Type: Insider sale
Amount: $767,600
Shares · price: 20,000 sh · $38.38 a share
Held after: 120,000 sh
Stock: Royalty Pharma RPRX
Person: Marshall UristEVP, Research & Investments
Trade date: 25/12/19
Filed: 25/12/22
Days to filing: 3 days

Sold 14.3% of holdings

Share of holding sold: 14.3%

Royalty Pharma trades, last 26 weeks

What else happened in Royalty Pharma around then

Filed or reported within 30 days of the trade day · 25/11/19~01/18

Marshall Urist's recent trades

Marshall UristEVP, Research & Investments
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$238.8K
4,126 sh
$238.8K
Filed 09/30
Traded 09/28
Marshall UristEVP, Research & Investments
Planned sale10b5-1 planRoyalty Pharma
Planned sale10b5-1 plan
Royalty Pharma
RPRX
$238.8K
4,126 sh
$238.8K
Filed 09/28
Traded 09/28
Marshall UristEVP, Research & Investments
Planned sale10b5-1 planRoyalty Pharma
Planned sale10b5-1 plan
Royalty Pharma
RPRX
$508.5K
9,099 sh
$508.5K
Filed 07/01
Traded 07/01
Marshall UristEVP, Research & Investments
Sell10b5-1 planRoyalty Pharma
Sell10b5-1 plan
Royalty Pharma
RPRX
$502K
9,098 sh
$502K
Filed 06/25
Traded 06/24
Marshall UristEVP, Research & Investments
Planned sale10b5-1 planRoyalty Pharma
Planned sale10b5-1 plan
Royalty Pharma
RPRX
$502.1K
9,098 sh
$502.1K
Filed 06/24
Traded 06/24